Positive Trial Results for Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S (LUN.CO)'s Abilify Maintena in Schizophrenia
5/22/2013
More...
|
Sunovion Pharmaceuticals Inc. Presents Data Showing 12 Months of Latuda® (lurasidone HCl) Treatment Resulted in Higher Remission Rates in Adult Patients With Schizophrenia Compared to Seroquel XR® (quetiapine XR)
5/21/2013
More...
|
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S (LUN.CO): Study Shows Effects of Treatment With ABILIFY MAINTENA#0153; (Aripiprazole) on Psychiatric Hospitalization Rates for Patients With Schizophrenia1
5/21/2013
More...
|
"Love Hormone" Promises Safer Births After Pfizer Inc. (PFE) Flop
5/21/2013
More...
|
Sunovion Pharmaceuticals Inc. Presents Results From a One-year, Large Simple Safety Study of BROVANA® (arformoterol tartrate) Inhalation Solution
5/20/2013
More...
|
UCB, Inc. (UCBJF.PK) Release: New Study Shows Effect of Neupro® (Rotigotine Transdermal System) on Cardiovascular Measures in Patients with Restless Legs Syndrome
5/17/2013
More...
|
Bristol-Myers Squibb Company (BMY) Drug Cocktail Stymies Melanoma Tumors
5/17/2013
More...
|
US WorldMeds, LLC Release: New Clinical Trial Investigates APOKYN for Treating Debilitating Morning Akinesia in Parkinson’s Disease Patients
5/13/2013
More...
|
Why Does Arena Pharmaceuticals, Inc. (ARNA)'s Obesity Drug Have Abuse Potential?
5/13/2013
More...
|
Sex Supplements Often Contain Viagra Ingredients, Pfizer Inc. (PFE) Reveals
5/10/2013
More...
|
Prometheus Laboratories Inc. Launches PROCLIVITY(SM) 01 Clinical Trial of Proleukin® (Aldesleukin for Injection) Plus Vemurafenib Therapy in Patients with Metastatic Melanoma
5/9/2013
More...
|
AlphaMed Release: Study Shows Dual Targeting of HER2 and HR-Positive Metastatic Breast Cancer Improves Survival Rates
5/7/2013
More...
|
Bristol-Myers Squibb Company (BMY) and Pfizer Inc. (PFE) Announce Publication of ARISTOTLE Subanalysis in Circulation
5/7/2013
More...
|
European Medicines Agency Ordered Not to Release AbbVie (ABBV)'s Trial Data, for Now
5/2/2013
More...
|
Pfizer Inc. (PFE)'s Celebrex Meets Goals in Juvenile Rheumatoid Arthritis Study
4/26/2013
More...
|
Genzyme Corporation (GENZ) Release: Once-Daily AUBAGIO® Delayed Onset of Clinically Definite Multiple Sclerosis (MS) in TOPIC Study
4/25/2013
More...
|
Pacira Pharmaceuticals, Inc. Release: New Data Support the Benefits of EXPAREL for Postsurgical Analgesia Following Aesthetic Plastic Surgery Procedures
4/12/2013
More...
|
Teva Pharmaceutical Industries Limited (TEVA) Parkinson's Treatment Meets Study Goals
3/20/2013
More...
|
German Cost Regulator Rejects Bayer AG (BAY.F) and Regeneron Pharmaceuticals, Inc. (REGN) Eye Drug
3/20/2013
More...
|
EU Expands Use of Roche (RHHBY)'s Pegasys in Chronic Hepatitis C
3/18/2013
More...
|
Ferring Pharmaceuticals Data Suggest Lower Risk of Cardiovascular Events or Deaths in Prostate Cancer Patients Treated With Degarelix Compared to LHRH Agonists
3/18/2013
More...
|
Merck & Co., Inc. (MRK) Says a Crucial Vytorin Study Will Continue
3/13/2013
More...
|
AbbVie (ABBV) Seeks to Block Release of Clinical Trial Data
3/11/2013
More...
|
Serious Side Effects Seen With Failed Merck & Co., Inc. (MRK) Niacin Drug
3/11/2013
More...
|
Pfizer Inc. (PFE)'s Eplerenone May Help Prevent Heart Failure in Acute Heart Attack Patients
3/11/2013
More...
|
Roche (RHHBY)'s Rituxan Cures Rare Skin-Blistering Disease in Study
3/8/2013
More...
|
Kowa Pharmaceuticals America Release: New Superiority Trial Showed LIVALO® (Pitavastatin) 4 mg Provided Significantly Greater LDL-C Reduction in HIV-Infected Adults With Dyslipidemia Versus Pravastatin 40 mg
3/7/2013
More...
|
National Institute for Clinical Excellence (NICE) U-Turn on Novartis AG (NVS)'s Xolair for Asthma
3/7/2013
More...
|
Merck & Co., Inc. (MRK)'s Tredaptive Raises Risk of Muscle Pain in Study
2/27/2013
More...
|
Boehringer Ingelheim Corporation Release: New Findings From Two Studies Support Substantial Benefit of Pradaxa® for Prevention of Recurrent Deep Vein Thrombosis and Pulmonary Embolism
2/21/2013
More...
|
Cumberland Pharmaceuticals (CPIX) Release: Caldolor® Reduces Pain and Fever in Adult Patients
2/19/2013
More...
|
Bristol-Myers Squibb Company (BMY) Diabetes Drug Helps Obese Adolescents Lose Weight
2/5/2013
More...
|
NPS Pharmaceuticals, Inc. (NPSP) Release: New Peer-Reviewed Publication Offers Guidance for Integrating Gattex® (Teduglutide [rDNA origin]) for Injection into Management of Short Bowel Syndrome
1/30/2013
More...
|
Pfizer Inc. (PFE) Reports Positive Results in Studies of Toviaz, Pristiq, Chantix
1/24/2013
More...
|
Santarus Inc. (SNTS) and VeroScience Announce Publication of Positive Data From Pivotal CYCLOSET® (bromocriptine mesylate) Efficacy Study
1/23/2013
More...
|
Novartis AG (NVS) Says Afinitor Reduces Tumors in Rare Genetic Disease
1/11/2013
More...
|
Merck & Co., Inc. (MRK)'s Tredaptive is Under Review by European Medicines Agency After Failed Trial
12/26/2012
More...
|
Merck & Co., Inc. (MRK) Cholesterol Drug Fails; Risks Seen
12/26/2012
More...
|
Pfizer Inc. (PFE)'s Chantix Produced More Heart Concerns, FDA Says
12/13/2012
More...
|
Immune Response BioPharma Files for Orphan Designation of REMUNE for Pediatric HIV/AIDS
12/13/2012
More...
|
Novo Nordisk A/S (NVO) Bets on Turning Victoza Into Obesity Blockbuster
12/12/2012
More...
|
Celgene (CELG) Release: REVLIMID® and VIDAZA® Combination Therapy Achieves Nearly 30 Percent Complete Response in Untreated Elderly Patients With Acute Myeloid Leukemia
12/11/2012
More...
|
Celgene International Sárl (CELG) Release: Analysis of Post-Progression Outcomes in MM-015 Study Presented at the 54th American Society of Hematology Annual Meeting
12/11/2012
More...
|
Genentech (RHHBY)'s Perjeta Extends Life of Breast Cancer Patients by 34 Pct
12/11/2012
More...
|
Boehringer Ingelheim Corporation Release: Treatment With Pradaxa® Associated With Better Patient Outcomes After a Major Bleeding Event Compared to Warfarin
12/10/2012
More...
|
Millennium: The Takeda Oncology Company Reports Positive Velcade Trial Data
12/10/2012
More...
|
GlaxoSmithKline (GSK): We Conducted Paxil Clinical Trial Program Appropriately
12/7/2012
More...
|
AstraZeneca PLC (AZN) Release: Final Overall Survival Analysis of CONFIRM Shows a 4.1 Month Difference in Median Overall Survival When Using FASLODEX® (fulvestrant) Injection 500 mg Compared With 250 mg.1,2
12/5/2012
More...
|
iCeutica Inc. Commences Clinical Program for Metaxalone SoluMatrix™
11/30/2012
More...
|
Eli Lilly and Company (LLY)'s ED Drug, Cialis, Shows Promise in Rare Muscle Disease
11/30/2012
More...
|
Digoxin for Atrial Fibrillation Questioned After Deaths, Study Published in the European Heart Journal
11/28/2012
More...
|
Novo Nordisk A/S (NVO) Says New Data Show Victoza Advantage
11/27/2012
More...
|
Roche (RHHBY)'s Avastin Shows Mixed Results in Glioblastoma
11/23/2012
More...
|
Pacira Pharmaceuticals, Inc. Release: New Data Demonstrate Reduction in Opioid Use, Hospital Cost and Length of Stay With EXPAREL as the Foundation of a Multimodal Regimen
11/20/2012
More...
|
Pamlab LLC Release: Metanx® Study Published in the American Journal of Pharmacy Benefits Indicates Treatment Lowers the Risk of Hospitalization and Decreases Disease-Related Costs
11/19/2012
More...
|
Study Shows Positive Results for Pfizer Inc. (PFE)'s Lyrica
11/19/2012
More...
|
Gilead Sciences, Inc. (GILD)'s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients
11/15/2012
More...
|
Gilead Sciences, Inc. (GILD)'s Once-Daily Single Tablet Regimen Stribild™ Maintains High Viral Suppression Through Two Years of Therapy Among Treatment-Naive HIV Patients
11/15/2012
More...
|
OncoSec Medical Inc. Reports Positive Interim Efficacy Results From Phase IV Study of NeoPulse in Skin Cancer Patients
11/14/2012
More...
|
Bed Bugs Dying After Merck & Co., Inc. (MRK) Drug Suggests Possible Weapon
11/14/2012
More...
|
ViroPharma Incorporated (VPHM)'s Cinryze® (C1 Esterase Inhibitor [Human]) Prophylaxis Study Showed Safety Data of Escalating Doses in Patients With Hereditary Angioedema
11/13/2012
More...
|
Bayer Corporation (BAY) Release: New Canadian-Led Global Study of Bayer's Xarelto® (rivaroxaban tablet), Initiated for the Secondary Prevention of Cardiovascular Death, Myocardial Infarction and Stroke in Patients With Coronary or Peripheral Artery Disease
11/13/2012
More...
|
Savient Pharmaceuticals, Inc. (SVNT) Release: New Data Demonstrate KRYSTEXXA®-Treated Refractory Chronic Gout Patients Experienced Significantly Improved Health-Related Quality of Life
11/13/2012
More...
|
UCB Group (UCBJF.PK) Announces Data on Cimzia® (certolizumab pegol) for Patients With Moderate to Severe Rheumatoid Arthritis at American College of Rheumatology 2012 Congress
11/13/2012
More...
|
Genentech (RHHBY) Presents Positive Data for Actemra in Rheumatoid Arthritis
11/12/2012
More...
|
Savient Pharmaceuticals, Inc. (SVNT) Release: New Data Published in Annals of the Rheumatic Diseases Confirm Long-Term Safety and Efficacy of KRYSTEXXA® for the Treatment of Refractory Chronic Gout
11/12/2012
More...
|
Horizon Pharma, Inc. (HZNP) Presents Clinical Data Demonstrating RAYOS® (prednisone) Delayed-Release Tablets Reduce Fatigue in Patients With Active Rheumatoid Arthritis
11/12/2012
More...
|
Plexxikon Inc. Announces Three-Year Survival in Zelboraf-Treated Metastatic Melanoma Patients
11/9/2012
More...
|
Boehringer Ingelheim Corporation Release: Recruitment Complete for Trajenta ® (linagliptin) Cardiovascular Outcome Study in Patients With Type 2 Diabetes
11/8/2012
More...
|
Boehringer Ingelheim Corporation Release: RELY-ABLE®: Unprecedented Long-Term Data Support Safety Profile and Sustained Efficacy of Pradaxa® for Stroke Prevention in AF
11/8/2012
More...
|
Eli Lilly and Company (LLY) Release: Cardiovascular Outcome Study on Tradjenta® (Linagliptin) Tablets in Adult Patients With Type 2 Diabetes Completes Enrollment
11/8/2012
More...
|
Okuvision GmbH Initiates Multi-Center, Post-Market Study
11/8/2012
More...
|
AstraZeneca PLC (AZN) Release: New PLATO Analysis Evaluates the Influence of High-Sensitivity Troponin Biomarker Status in NSTE-ACS Patients Managed With Revascularization or Medical Management
11/7/2012
More...
|
Boehringer Ingelheim Corporation Release: Safety and Efficacy of Pradaxa® (dabigatran etexilate) Reconfirmed in Clinical Setting for VTE Prevention After Total Knee or Hip Replacement
11/6/2012
More...
|
Novartis AG (NVS) Drug Works to Treat Rare Cushing's Disease
11/6/2012
More...
|
Boehringer Ingelheim GmbH Release: FDA and FDA Reaffirm Important Health Benefits and Safety of Pradaxa® (dabigatran etexilate) for Patients With Atrial Fibrillation
11/5/2012
More...
|
GlaxoSmithKline (GSK), Roche (RHHBY) Drugs Help Treat Breast Cancer in Brain
11/2/2012
More...
|
Data in The New England Journal of Medicine Show Novartis AG (NVS) Drug Aclasta® Significantly Reduced the Risk of Fracture in Men With Osteoporosis With Once-Yearly Infusion
11/1/2012
More...
|
Wealth of Worldwide Evidence on Boehringer Ingelheim GmbH's Pradaxa® Including First Clinical Data on Long-Term Efficacy and Safety of a Novel Oral Anticoagulant to be Presented at American Heart Association Scientific Sessions
10/31/2012
More...
|
ASTRO Release: Sildenafil Citrate Improves Overall Sexual Function of Prostate Cancer Patients Receiving Radiation Therapy
10/29/2012
More...
|
Novartis AG (NVS) Cannibalizes Gleevec to Boost New Cancer Drug
10/29/2012
More...
|
Celgene International Sárl (CELG) Release: ABRAXANE® Demonstrates Significant Improvement in Progression-Free Survival Compared to Standard Chemotherapy in Advanced Melanoma Patients
10/25/2012
More...
|
Eli Lilly and Company (LLY) Release: New Retrospective Studies of Hospital Readmission Rates for Subsequent Heart Attack and Initial Hospitalization Costs in ACS-PCI Patients Treated with Effient® (Prasugrel) or Plavix® (Clopidogrel) Presented at TCT
10/24/2012
More...
|
Abbott Laboratories (ABT) Announces Three-Year Long-Term Data Evaluating Efficacy with HUMIRA® (Adalimumab) for Patients With Moderately to Severely Active Ulcerative Colitis
10/23/2012
More...
|
Zogenix, Inc. to Present New Case Study Highlighting Successful Repositioning of Injectable Sumatriptan for Migraine With a Novel Needle-Free Delivery Technology
10/23/2012
More...
|
Sleep Tight: GlaxoSmithKline (GSK) Vaccine Not Linked To Narcolepsy
10/19/2012
More...
|
Pfizer Inc. (PFE) Kidney Cancer Drug Fails as Initial Treatment
10/18/2012
More...
|
Eisai Company, Ltd. (ESALY.PK)'s Epilepsy Drug Helps Obese Patients Lose Weight
10/17/2012
More...
|
Drugs Including Pfizer Inc. (PFE)'s Lipitor Help Cholesterol Declines in U.S. as Obesity Rises
10/17/2012
More...
|
Abbott Laboratories (ABT)' Hepatitis C Drugs Clear Virus in 99% of Patients
10/16/2012
More...
|
Pfizer Inc. (PFE) Release: New Study With CHANTIX®/CHAMPIX® (Varenicline) Tablets Suggests Favorable Benefit-Risk Profile in Adult Smokers With Major Depressive Disorder
10/16/2012
More...
|
Sanofi (France) (SAN.PA)'s Genzyme Corporation (GENZ) Makes Progress With MS Drugs
10/15/2012
More...
|
Novartis AG (NVS)'s Gilenya Cuts Early Relapse, Brain Loss in MS Patients
10/12/2012
More...
|
Biogen Idec, Inc. (Massachusetts) (BIIB) Release: TYSABRI® (natalizumab) Data at ECTRIMS Reaffirm Positive Effects of Treatment for People With Relapsing Forms of MS
10/11/2012
More...
|
Canyon Pharmaceuticals' DESIR-ABLE Study Completed
10/10/2012
More...
|
Acorda Therapeutics (ACOR) Release: AMPYRA® Two-Year Safety Data Presented at 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
10/10/2012
More...
|
Oculus Innovative Sciences, Inc. (OCLS) Announces Results From Study of Microcyn® Technology-Based Atrapro™ Antipruritic Hydrogel Used in Combination With Neosalus® Cream in Treatment of Atopic Dermatitis
10/9/2012
More...
|
Sanofi (France) (SAN.PA) Says Zaltrap Cancer Drug Study Positive
10/9/2012
More...
|
Sanofi (France) (SAN.PA) Flags Positive Study on Lantus Insulin
10/5/2012
More...
|
ViroPharma Incorporated (VPHM) Presents New Cinryze™ (C1 Esterase Inhibitor [Human]) Data on Site of Care and Adherence at the 2012 Academy of Managed Care Pharmacy Educational Conference
10/5/2012
More...
|
Celgene Corporation (CELG)'s Revlimid Combo Fails as Prostate Cancer Therapy
10/5/2012
More...
|
Drug Relieves Major Depression in Hours Instead of Weeks, Yale University Study Reveals
10/5/2012
More...
|
Allergan Inc. (AGN)'s Botox Shot Helps Overactive Bladder in Women
10/4/2012
More...
|
Janssen Biotech Inc. Release: New Data Demonstrate STELARA® (Ustekinumab) is Effective and Improves Quality of Life in Patients With Moderate to Severe Plaque Psoriasis
10/3/2012
More...
|
Merck & Co., Inc. (MRK)'s HPV Vaccine Gardasil Shown Safe in Kaiser Permanente Study
10/2/2012
More...
|
Pfizer Inc. (PFE) Lung Cancer Drug Doubles Benefit, Researchers Say
10/2/2012
More...
|
Celgene (CELG)'s Abraxane is Talk of Cancer Meeting
10/1/2012
More...
|
Cancer Trials Show One Year on Roche (RHHBY)'s Herceptin is Best
10/1/2012
More...
|
New Janssen Pharmaceutica N.V. Data Demonstrate STELARA® (ustekinumab) is Effective, Well-Tolerated and Improved Quality of Life in Patients With Moderate to Severe Plaque Psoriasis
9/28/2012
More...
|
Genomic Health, Inc. Announces Presentation of Three Oncotype DX® Studies in Breast and Colon Cancers at the 2012 European Society for Medical Oncology Congress
9/28/2012
More...
|
First Patient in Dendreon Corporation (DNDN) EU Open-Label Study Begins Sipuleucel-T Infusion Treatment
9/28/2012
More...
|
Medicure Inc. (MCU) Announces Development of Novel Aggrastat Formulation
9/26/2012
More...
|
AstraZeneca PLC (AZN) Release: New PLATO Sub-Analysis Suggests Patients’ Age Had No Impact on Study Finding of a Greater Reduction in Thrombotic Cardiovascular Events With BRILINTA (ticagrelor) Compared to Clopidogrel
9/24/2012
More...
|
Pilot Study in Patients With Head and Neck Cancer Finds That Derma Sciences, Inc. (DSCI)' MEDIHONEY® Reduces Hospital Stays in the U.K.
9/21/2012
More...
|
FDA Lifts Temporary Hold on ViroPharma Incorporated (VPHM) Treatment
9/21/2012
More...
|
Savient Pharmaceuticals, Inc. (SVNT) Announces Multiple Abstracts Related to KRYSTEXXA® in the Treatment of Refractory Chronic Gout to be Presented at the 2012 ACR/ARHP Annual Meeting
9/20/2012
More...
|
Spectrum Pharmaceuticals, Inc. (SPPI) Initiates Phase 3 Study of ZEVALIN® in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL); Most Common Form of Aggressive Non-Hodgkin's Lymphoma
9/19/2012
More...
|
Cumberland Pharmaceuticals (CPIX) Release: Caldolor™ Reduces Narcotic Doses in Pediatric Pain Patients
9/19/2012
More...
|
JHP Pharmaceuticals to Produce Lyophilized Biologic for International Late-Phase Clinical Trials
9/19/2012
More...
|
Apricus Biosciences (APRI) Announces Publication in Journal of Pharmaceutics and Drug Delivery Research
9/18/2012
More...
|
New Study Demonstrating Progenra, Inc.'s Novel Anti-Tumor Compound Overcome VELCADE® (bortezomib) Resistant Multiple Myeloma Cells
9/17/2012
More...
|
NovaBay Pharmaceuticals, Inc.'s NeutroPhase® Used in New Therapeutic Technique for Management of Necrotizing Fasciitis
9/13/2012
More...
|
AtriCure, Inc. (ATRC) Launches Three-Year Post-Approval Study for the Surgical Correction of Atrial Fibrillation
9/13/2012
More...
|
Genomic Health, Inc. Announces Presentation of Two Oncotype DX® Studies at the 2012 Breast Cancer Symposium
9/13/2012
More...
|
Boehringer Ingelheim GmbH Release: Asian Populations With Atrial Fibrillation (AF) Benefit From Better Stroke Prevention With Pradaxa® (dabigatran etexilate) Compared to Warfarin
9/12/2012
More...
|
Discovery Laboratories (DSCO) Release: Newly-Published Study Compares SURFAXIN® With Animal-Derived Surfactants in Well-Established Model of RDS
9/7/2012
More...
|
AstraZeneca PLC (AZN) Release: New Data Suggest Patient Smoking Habits Had No Impact on PLATO Study Findings of a Greater Reduction in Thrombotic Cardiovascular Events with BRILINTA (ticagrelor) Compared to Clopidogrel
9/6/2012
More...
|
Boehringer Mannheim Corporation, Pfizer Inc. (PFE)'s Drug Helped to Delay Asthma Attacks
9/5/2012
More...
|
New Data Confirms Safety of Novartis AG (NVS)'s Eye Drug Lucentis
9/5/2012
More...
|
Novartis AG (NVS) Smoker's Cough Treatment Beats GlaxoSmithKline (GSK)'s Advair in Trial
8/29/2012
More...
|
Bayer AG (BAY.F) Says Blood Thinner Cuts Risk of Repeat Heart Attack
8/29/2012
More...
|
The Medicines Company (MDCO) Release: Latest European Heart Attack Treatment Guidelines Recommend Angiomax(R)/Angiox(R) (Bivalirudin) Over Heparin
8/28/2012
More...
|
AstraZeneca PLC (AZN) Release: New European Society of Cardiology Guidelines Recommend BRILINTA (Ticagrelor) in Acute Coronary Syndromes Patients With ST-Elevation
8/28/2012
More...
|
Vaccinogen Release: Human Vaccines & Immunotherapeutics Special Focus Highlights a Paradigm Shift in Cancer Vaccine Development
8/28/2012
More...
|
Daiichi Sankyo, Inc. (4568.t), Eli Lilly and Company (LLY) Say Heart Drug Effient Fails to Meet Goal in a Phase III Trial
8/27/2012
More...
|
Boehringer Ingelheim Corporation Release: Cost Effectiveness and Clinical Efficacy of Pradaxa® (Dabigatran Etexilate) Versus Rivaroxaban Analysed
8/24/2012
More...
|
Abbott Laboratories (ABT) Humira May Not be Effective in Colitis, FDA Says
8/24/2012
More...
|
NanoViricides, Inc. (NNVC.PK) Reports That Oral Administration of FluCide® Anti-Influenza Drug Candidates Led to Survival Improvements Comparable to IV Administration and Was Far Superior to Oseltamivir, in a Highly Lethal Animal Model
8/20/2012
More...
|
Nectid Announces Initiation of Clinical Development of Autism And Pain Drugs
8/16/2012
More...
|
Acorda Therapeutics (ACOR)' Ampyra Fails Main Goal of Post-Marketing Study
8/14/2012
More...
|
Bionor Pharma ASA Release: Study of Vacc-4x Combined With Celgene (CELG)'s Revlimid® (lenalidomide) in HIV Patients With Impaired Immune System Approved to Begin
8/13/2012
More...
|
Pfizer Inc. (PFE)'s Torisel Drug Fails in a Combination Study
8/13/2012
More...
|
Roche (RHHBY) Says Avastin Slows Brain Cancer Tumor Growth
8/10/2012
More...
|
SaneVax Announces Medical Surprise: Gardasil®HPV DNA Discovered in Post-Mortem Blood and Spleen Tissue
8/9/2012
More...
|
Head-to-Head Back Pain Study Finds No Difference Between Eli Lilly and Company (LLY)'s Forteo and Warner Chilcott, PLC (WCRX)'s Actonel
8/8/2012
More...
|
Pfizer Inc. (PFE) Release: Study Shows Toviaz is Effective in Reducing Urge Urinary Incontinence in Patients With Overactive Bladder After Suboptimal Response to Detrol LA
8/3/2012
More...
|
Johnson & Johnson (JNJ) Provides Added Doxil Supply for Clinical Studies
8/3/2012
More...
|
Delivra™ Announces Completion of an Analytical Skin Absorption Study for LivRelief Topical Pain Relief Cream
8/1/2012
More...
|
Bristol-Myers Squibb Company (BMY) & AstraZeneca PLC (AZN) Release: Pooled Analysis Showed Onglyza® (saxagliptin) Provided Improvements in Key Measures of Blood Sugar Control in Adults With Type 2 Diabetes at High Risk for CV Disease
7/30/2012
More...
|
AIDS Cure Seen as Possible After Hint of Success Seen in Merck & Co., Inc. (MRK) Drug Study
7/30/2012
More...
|
ViroPharma Incorporated (VPHM)'s Cinryze® (C1 esterase inhibitor [human]) Open Label Prophylaxis Study Showed Up to 2.6 Years of Effectiveness in Majority of Subjects With Hereditary Angioedema
7/27/2012
More...
|
Spectrum Pharmaceuticals, Inc. (SPPI) Announces Publication Demonstrating Enhanced Survival With ZEVALIN in Premier Medical Journal Blood
7/26/2012
More...
|
Roche (RHHBY)'s Lucentis Works to Treat Vision Loss from Diabetes
7/25/2012
More...
|
Bayer AG (BAY.F), Onyx Pharmaceuticals, Inc. (ONXX) Says Nexavar-Tarceva Trial Unsuccessful
7/24/2012
More...
|
Merck & Co., Inc. (MRK) Reports Positive Isentress Data
7/23/2012
More...
|
Pfizer Inc. (PFE)'s Lyrica Meets Goals in US, Europe Studies
7/23/2012
More...
|
Kowa Pharmaceuticals America, Eli Lilly and Company (LLY) Release Results From a Pharmacokinetic Study
7/23/2012
More...
|
Biogen Idec, Inc. (Massachusetts) (BIIB), Bayer AG (BAY.F) Drugs Fail to Slow MS Progression
7/19/2012
More...
|
Baxter International, Inc. (BAX) Alzheimer's Drug Keeps Four Patients Stable for 3 Years
7/19/2012
More...
|
AMAG Pharmaceuticals, Inc. (AMAG) Unveils Positive Results From Iron-Deficiency Anemia Drug Feraheme
7/18/2012
More...
|
AstraZeneca PLC (AZN) Starts New Study of Heart Drug Versus Rival
7/18/2012
More...
|
Gilead Sciences, Inc. (GILD)'s Truvada Pill Urged for AIDS Prevention After Promising Studies
7/12/2012
More...
|
Merck & Co., Inc. (MRK) Accused of Lying About Vaccine Effectiveness
7/11/2012
More...
|
GlaxoSmithKline (GSK), Shionogi & Co., Ltd. Say HIV Drug Beats Gilead Sciences, Inc. (GILD) Atripla in Test
7/11/2012
More...
|
Merck KGaA (MKGAF.PK) Says Erbitux Fails in Stomach Cancer Trial
7/6/2012
More...
|
Little Addicts? Purdue Pharma L.P. to Test OxyContin on Kids
7/3/2012
More...
|
Orexo AB Takes Large Step Forward on the Road to Improve Treatment for People Dependent on Opioid Pain Killers
7/2/2012
More...
|
Onyx Pharmaceuticals, Inc. (ONXX) Initiates Phase 3 Kyprolis™ Head-to-Head Comparison Trial vs. Velcade® in Patients With Relapsed Multiple Myeloma
7/2/2012
More...
|
Vertex Pharmaceuticals Incorporated (VRTX) Offers More Evidence for Cystic Fibrosis Drug
6/29/2012
More...
|
Shire plc Gaucher Drugs Beats Shire Pharmaceuticals (SHPGY) Med in Trial
6/28/2012
More...
|
Merck & Co., Inc. (MRK) Release: Patients with Type 2 Diabetes Fasting for Ramadan in India and Malaysia Were About Half as Likely to Experience Low Blood Sugar When Switched from a Sulfonylurea to MSD’s JANUVIA® (sitagliptin)
6/28/2012
More...
|
Access Pharmaceuticals (ACCP) Announces Positive Data From MuGard Phase 4 Clinical Trial In Oral Mucositis At MASCC/ISOO 2012 Symposium
6/28/2012
More...
|
Access Pharmaceuticals (ACCP) to Report New MuGard Clinical Trial Data This Week at the MASCC/ISOO Symposium in New York City
6/27/2012
More...
|
CSL Behring Release: PRIMA Study Shows Treatment with Privigen® Improved Function in Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
6/27/2012
More...
|
FDA: Amylin Pharmaceuticals, Inc. (AMLN) Concealed Heart Safety Risks of Key Diabetes Drug
6/27/2012
More...
|
Boehringer Ingelheim Corporation Release: No Significant Difference in the Risk of Acute Coronary Syndrome (including Myocardial Infarction) Seen With Pradaxa®(dabigatran etexilate) Compared to Enoxaparin for VTE Prevention After Orthopaedic Surgery
6/25/2012
More...
|
Genentech (RHHBY) Says Perjeta Combination Increased Survival in Breast Cancer Patients
6/22/2012
More...
|
Boehringer Ingelheim Corporation Release: First Study to Evaluate Alternative to Warfarin for Mechanical Heart Valve Patients Launched with Pradaxa® (dabigatran etexilate)
6/20/2012
More...
|
Bristol-Myers Squibb Company (BMY) Hep. C Trial Change Has Big Implications
6/20/2012
More...
|
FDA Focuses on Toxic Side Effects With Onyx Pharmaceuticals, Inc. (ONXX) Drug
6/20/2012
More...
|
Pfizer Inc. (PFE): Xalkori Improves Lung Cancer Patients' Survival in Phase III Trial
6/19/2012
More...
|
Boehringer Ingelheim GmbH Release: AF Patients Who Require Surgery Benefit From a Shorter Treatment Interruption on Dabigatran Etexilate (Pradaxa®) Compared to Warfarin
6/18/2012
More...
|
Spectrum Pharmaceuticals, Inc. (SPPI) Announces Outstanding ZEVALIN® Clinical Data In Aggressive Relapsed/Refractory Lymphoma; Presented at the 17th Congress of the European Hematology Association
6/18/2012
More...
|
FDA Staff Question Value of Sanofi (France) (SAN.PA) Blood Clot Drug
6/18/2012
More...
|
Sanofi (France) (SAN.PA) Announces Results of ORIGIN, the World's Longest and Largest Randomised Clinical Trial in Insulin in Pre- and Early Diabetes
6/15/2012
More...
|
GlaxoSmithKline (GSK)'s Avandia and University of Nottingham's Actos are Linked to Vision Problems
6/13/2012
More...
|
New Epidemiological Data Provide Additional Safety Evidence for Sanofi (France) (SAN.PA)'s Lantus(R)
6/12/2012
More...
|
Alkermes plc (ALKS) Release: INVEGA® SUSTENNA® Three-Month Formulation of Paliperidone Palmitate Enters Phase 3 Clinical Program for Schizophrenia
6/12/2012
More...
|
Sanofi (France) (SAN.PA)'s Lantus Shows No Cancer, Heart Risks: Study
6/12/2012
More...
|
Novo Nordisk A/S (NVO) Says Victoza Superior to Amylin Pharmaceuticals, Inc. (AMLN) Rival
6/12/2012
More...
|
Amylin Pharmaceuticals, Inc. (AMLN) Release: SYMLIN® Use Helped Patients With Type 2 or Type 1 Diabetes Achieve More Time in Normal Glucose Range
6/11/2012
More...
|
Amylin Pharmaceuticals, Inc. (AMLN) Release: BYDUREON™ Was Associated With Significant and Sustained Glycemic Control at Four Years
6/11/2012
More...
|
Amylin Pharmaceuticals, Inc. (AMLN) Release: Once-Weekly BYDUREON™ Provided Greater Glucose Control, Weight Loss and Lower Risk of Hypoglycemia Compared to Once- or Twice-Daily Levemir® in Type 2 Diabetes
6/11/2012
More...
|
Amylin Pharmaceuticals, Inc. (AMLN) Release: BYETTA® Provided Greater Glycemic Durability and Overall Glycemic Control than Amaryl® in Patients with Type 2 Diabetes
6/11/2012
More...
|
Amylin Pharmaceuticals, Inc. (AMLN) Release: BYDUREON™ Improved A1C, Fasting Glucose, Pulse Pressure and Weight Regardless of Baseline Body Weight in Patients With Type 2 Diabetes
6/11/2012
More...
|
Halozyme Therapeutics, Inc. (HALO) Release: Interim Data From Pre-administration of Hylenex in Analog Insulin Pump Therapy Demonstrate Consistent Insulin Action Profile: Data Presented in Late-Breaker Poster at American Diabetes Association 2012
6/11/2012
More...
|
Sanofi (France) (SAN.PA) Release: Lyxumia® (lixisenatide) in Combination with Basal Insulin Plus Oral Anti-Diabetics Significantly Reduced HbA1c and Post-Prandial Glucose
6/11/2012
More...
|
Ampio Pharmaceuticals, Inc. (AMPE) Release: Announces Positive Clinical Trial Results for the Treatment of Diabetic Macular Edema with Orally Administered Optina(TM)
6/11/2012
More...
|
Sanofi (France) (SAN.PA)'s Lantus Cut Blood Sugar More Than Merck & Co., Inc. (MRK)'s Januvia
6/11/2012
More...
|
Amgen (AMGN) Drug Sensipar Fails to Meet Trial Goal
6/11/2012
More...
|